Navigation Links
Differences observed between black and white women in use of breast cancer therapy
Date:10/7/2007

A new study finds treatment for breast cancer differs between African-American women and white women, though the differences are partly dependent on insurance type. The study appears in the November 15, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

Dr. Mousumi Banerjee of the University of Michigan and co-investigators Dr. Kendra Schwartz from Wayne State University and Dr. William Hryniuk from the Cancer Advocacy Coalition of Canada reviewed and analyzed demographic, socioeconomic and medical data from 651 women diagnosed with breast cancer in the early to mid 1990s. Their objective was to evaluate the role of race in breast cancer treatment after accounting for such significant confounders as comorbidities, socioeconomic status, and health insurance status.

The study found that, among patients with breast cancer that had spread to the lymph nodes, African-Americans were less likely to have adjuvant cancer therapy than white women. In this clinical group, white women were almost five times more likely to take Tamoxifen, a widely-used cancer therapy medication, and over three times more likely to have chemotherapy. Women with early stage breast cancer who had government health insurance were less likely to have combination breast conserving cancer surgery and radiation, and more likely to have mastectomy without radiation than patients enrolled in non-governmental plans.

Racial differences in the diagnosis and outcome of breast cancer have been readily apparent since the 1980s, when new screening and treatment tools became available. Breast cancer is diagnosed at a more advanced, poor prognostic stage among African-American women than white American women. Studies also suggest that, stage-for-stage, African-American women have higher cancer mortality rates. Differences in access to screening and treatment infrastructure, rather than tumor biology, may account for differences in clinical course.


'/>"/>
Contact: Amy Molnar
amolnar@wiley.com
John Wiley & Sons, Inc.
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Genetic differences found between Male and Female brains
2. Life anticipation differences identified
3. Differences in brain pattern among liars and cheats in comparison to honest people
4. Functional Differences In Estrogen Receptor Could Be A Therapeutic Target
5. Racial differences show difference in blood sugar control too!!
6. Greater g factor in men responsible for sex differences in general mental ability
7. Ethnic Differences in Healthcare
8. Ethnic Variations in Hormone Levels May Cause Differences in Breast Cancer Risk
9. Wide Differences between NHS staff and ministers
10. Women in the throes of depression portray differences in brain chemistry
11. Differences Between BP Medicines and Newly-Diagnosed Diabetes Identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... “Many people become overwhelmed by the ... issues and phone calls with insurance companies,” The Jones ... their free eBook on pedestrian and bicycle accidents ... and bicycle auto accident claims assures the injured individual ... professionally handling their case while they focus on recovering. ...
(Date:12/26/2014)... PA (PRWEB) December 26, 2014 Pentec ... Work in the state of Pennsylvania for 2014. The ... first statewide programs of its kind in the country. ... Foundation, the Pennsylvania Department of Community and Economic Development, ... Resource Management and the Central Penn Business Journal. ...
(Date:12/26/2014)... 26, 2014 Parker & Sons, ... best in heating, cooling and plumbing contractor services ... emergency services in 2014 with regard to air-conditioning ... Arizona is known for its incredibly hot summers. ... the intricacies and details of a wide variety ...
(Date:12/25/2014)... 2014 This is a professional and ... Sterilizers industry with a focus on the Chinese market. ... of the Sterilizers manufacturers and is a valuable source ... in the industry. This report provides a basic overview ... technology. In this part, the report presents the company ...
(Date:12/25/2014)... 2014 The report “Nintedanib (Colorectal ... focuses on the current treatment landscape, unmet needs, ... cancer market. Stivarga is a drug which is ... cancer. Boehringer Ingelheim is developing nintedanib (BIBF-1120), an ... refractory CRC in the US, Europe, and Japan. ...
Breaking Medicine News(10 mins):Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4
... illness and death, study shows , TUESDAY, Oct. 13 ... a shorter life span, Australian researchers have found. , ... impairment with an increased risk of death from such ... index, slow walking speeds, a greater likelihood of falls, ...
... the technique, researchers say, but surgeon,s experience is key ... risks for post-operative incontinence and impotence may outweigh any ... a new study suggests. , The presumed good stemming ... public that is all too willing to believe, said ...
... long-term use, new review finds , TUESDAY, Oct. 13 (HealthDay ... phone-brain tumor connection finds a weak potential link between the ... topic, published online Oct. 13 in the Journal of ... spotlight was turned on only the more methodologically rigorous studies, ...
... cause trouble, so more study is needed, experts say , ... some old data adds convincing evidence that high body fluid ... of Parkinson,s disease. , However, the researchers also warned of ... , "The study doesn,t prove that urate is slowing down ...
... Oct. 13 In a recent survey of healthcare ... were more important to their organizations than they were ... of mobile productivity and management software, published a free ... for download at www.netmotionwireless.com/resources/whitepapers . , ...
... Hoag Hospital,s OB hospitalists provide immediate care onsite 24/7, ... BEACH, Calif., Oct. 13 Hoag is one of the ... Program in its labor and delivery unit. Hoag,s specialized program ... hospital 24 hours a day, seven days a week to ...
Cached Medicine News:Health News:Impaired Vision May Shorten Life Span 2Health News:Impotence, Incontinence Risk Casts Doubt on High-Tech Prostate Surgery 2Health News:Impotence, Incontinence Risk Casts Doubt on High-Tech Prostate Surgery 3Health News:Study Suggests Link Between Cell Phones and Brain Tumors 2Health News:Study Suggests Link Between Cell Phones and Brain Tumors 3Health News:Study Suggests Link Between Cell Phones and Brain Tumors 4Health News:Common Antioxidant Might Slow Parkinson's 2Health News:Common Antioxidant Might Slow Parkinson's 3Health News:NetMotion Wireless Publishes New Healthcare White Paper: Secure, Reliable Connections for Better Patient Care 2Health News:NetMotion Wireless Publishes New Healthcare White Paper: Secure, Reliable Connections for Better Patient Care 3Health News:Hoag OB Hospitalist Program Expands Exceptional Care for Pregnant and Laboring Women 2Health News:Hoag OB Hospitalist Program Expands Exceptional Care for Pregnant and Laboring Women 3
(Date:12/24/2014)... -- Tianyin Pharmaceutical Inc. (NYSE Amex: ... the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), ... unaudited preliminary financial results for the first quarter ... 2015 Ended September 30, 2014 Financial Highlights: ... million in 1Q14 with gross margins improved to ...
(Date:12/24/2014)... 2014  Conkwest, Inc., the Natural Killer Cell ... Killer (NK) cell-line platform, Neukoplast® (NK-92™) as an ... , NantWorks founder, physician scientist and biotechnology entrepreneur, ... approximately $48 million of the Company,s Class A ... will be named Co-Chairman of the Conkwest Board ...
(Date:12/24/2014)... SCHOFIELD, Wis. , Dec. 23, 2014 ... and marketer of over-the-counter (OTC) medicinal and healthcare products, ... production of MigraPure® H, a hemp-based, advanced headache relief ... marijuana dispensaries in Colorado , ... . With the MigraPure H Advanced ...
Breaking Medicine Technology:TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3
... Ingelheim Pharmaceuticals, Inc. (BIPI) today announced plans to ... the safety and pharmacokinetics of dabigatran etexilate in ... 12-week study will compare three doses of dabigatran ... to warfarin in patients with both aortic valve ...
... politicians, patients and physicians gathered on the grounds of ... last week to celebrate the inauguration of Central America,s ... Quemados y Cirugia Pediatrica Ruth Paz. The ceremony was ... in Central America. The facility,s establishment was made possible ...
Cached Medicine Technology:Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 2Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 3Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 4Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 5Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 6Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 7Carolinas HealthCare System (CHS) Contributes to First Children's Burn Hospital in Central America 2Carolinas HealthCare System (CHS) Contributes to First Children's Burn Hospital in Central America 3
Integrated electronics, three-chip CCD camera with PAL and NTSC output at 750 lines, RGB-video. 44mm x 49mm x 75mm, 180 grams....
Large image and wide-angle design....
High intensity halogen lamp with built-in, switchable spare. Optical light concentrator to optimize existing light energy....
PDA application listing specific ICD-9 coding listed in new Medicare National Coverage Determinations....
Medicine Products: